Literature DB >> 27928406

Late Presentation of Ataxia, Areflexia, and Electrophysiological Abnormalities as Part of Miller Fisher Syndrome: Case Report.

Deniz Somer1, Arzu Yilmaz2, Serap Tiras Teber3, Fatma Gul Cinar1.   

Abstract

Miller Fisher syndrome (MFS) is characterised by the triad of ophthalmoplegia, ataxia, and areflexia. A case with external ophthalmoplegia and absence of ataxia and areflexia until the end of second week is presented. Electrophysiological findings became apparent after the third week and showed reduced amplitudes of sensory nerve action potentials and prolonged latencies of F with no evidence of conduction blocks. There was no response to intravenous immunoglobulin, but there was response to corticosteroids. This case may represent an atypical MFS with late presenting electrophysiological abnormalities. Corticosteroids can be a therapeutic option when intravenous immunoglobulin fails to control clinical symptoms.

Entities:  

Keywords:  Acute esotropia; Miller Fisher syndrome; esotropia; external ophthalmoplegia; ophthalmoplegia

Year:  2016        PMID: 27928406      PMCID: PMC5123134          DOI: 10.1080/01658107.2016.1192197

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  11 in total

1.  Acute ophthalmoparesis (without ataxia) associated with anti-GQ1b IgG antibody: clinical features.

Authors:  N Yuki; M Odaka; K Hirata
Journal:  Ophthalmology       Date:  2001-01       Impact factor: 12.079

2.  Unilateral ophthalmoparesis and limb ataxia associated with anti-GQ1b IgG antibody.

Authors:  K Susuki; N Yuki; M Muramatsu; K Hirata
Journal:  J Neurol       Date:  2000-08       Impact factor: 4.849

Review 3.  Miller Fisher syndrome: brief overview and update with a focus on electrophysiological findings.

Authors:  Z Arányi; T Kovács; I Sipos; D Bereczki
Journal:  Eur J Neurol       Date:  2011-06-01       Impact factor: 6.089

4.  An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia).

Authors:  M FISHER
Journal:  N Engl J Med       Date:  1956-07-12       Impact factor: 91.245

5.  Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome.

Authors:  A Chiba; S Kusunoki; T Shimizu; I Kanazawa
Journal:  Ann Neurol       Date:  1992-06       Impact factor: 10.422

6.  Successful steroid treatment for recurrent Miller Fisher syndrome.

Authors:  Shuta Toru; Maya Ohara; Yumiko Hane; Taro Ishiguro; Takayoshi Kobayashi
Journal:  Muscle Nerve       Date:  2012-05       Impact factor: 3.217

7.  Lesion site in Fisher's syndrome.

Authors:  O Meienberg
Journal:  Arch Neurol       Date:  1984-03

Review 8.  Recurrent Miller Fisher syndrome in children.

Authors:  Salvatore Grosso; Alberto Verrotti; Monica Tei; Sara Cornacchione; Fabio Giannini; Paolo Balestri
Journal:  Pediatr Neurol       Date:  2013-10-31       Impact factor: 3.372

Review 9.  Neuro-ophthalmic manifestations of the syndrome of ophthalmoplegia, ataxia and areflexia: a review.

Authors:  S N al-Din; M Anderson; O Eeg-Olofsson; J V Trontelj
Journal:  Acta Neurol Scand       Date:  1994-03       Impact factor: 3.209

10.  Proposed mechanism of ataxia in Fisher's syndrome.

Authors:  A H Ropper; B Shahani
Journal:  Arch Neurol       Date:  1983-09
View more
  1 in total

1.  Ocular Manifestations of Miller Fisher Syndrome: a Case Report.

Authors:  Maja Malenica Ravlic; Lana Knezevic; Iva Krolo; Jelena Skunca Herman
Journal:  Med Arch       Date:  2021-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.